Position in ANNX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$3,114,481
+$299,547 QoQ
Shares Held
562,181
+0.3% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 80.43210282809274.ToString("F0")%
Shared 0.ToString("F0")%
None 19.567897171907266.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. ANNX ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ANNX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,114,481 | 562,181 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,814,934 | 560,744 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,588,263 | 1,504,349 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,227,475 | 511,448 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,036,977 | 537,294 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,752,260 | 536,503 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $3,007,685 | 508,055 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,428,881 | 495,690 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,117,681 | 155,883 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $712,789 | 157,002 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $446,378 | 126,812 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $488,226 | 126,812 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $655,618 | 126,812 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $783,698 | 126,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $478,081 | 126,812 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $392,399 | 143,736 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $217,666 | 18,944 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $333,807 | 17,937 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $416,682 | 18,511 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $489,426 | 17,580 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $286,267 | 11,437 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $237,879 | 7,869 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||